Clinical Research Network (CRN) South London's funding principles

Contents

The key principles for funding in 2022/2023 and 2023/2024

1. supporting stable allocations of funding to ensure that the whole portfolio of work can be supported as best as possible within south London
2. to ensure that national and local initiatives can be supported as required

Key additional highlights for our funding principles for 2023/2024

1. stable funding allocation from 2022/2023 to 2023/2024
2. a proportionate share of uplift funding provided to partners
3. the provision of £250,000 to ‘Greenshoots’ initiatives, residual funding has gone into a new call for an Associate Principal Investigator ’Greenshoots’ short-term scheme
4. stable funding for all core services within the CRN central leadership and management team
5. research support will continue to be provided through a combination of core funding to trusts and agile staff; the agile workforce will be employed through a number of partners but managed by the CRN team
6. a ring-fenced fund of £750,000 to support the provision of central services in primary care
7. the Transformation of Research funding of £757,576 has been ring-fenced to support the work of our Direct Delivery Team to work across community, social care and public health
8. a two per cent ring-fenced pot (£543,425) for under-served communities was awarded after a competitive call for funding
9. an in-year contingency fund of any residual and unallocated funding and where savings occur throughout the year. The fund will open to applicants in June
10. the balance of agile workforce funding, compared to core allocations, was maintained at the level allocated in the last financial year, with any savings being used to augment in-year contingency

The funding model for 2023/2024 was agreed initially on an almost flat allocation of funding across the CRN South London from the previous year. Where an additional cost-pressure award was made, this was distributed to partners proportionally.